Medulloblastoma: a population-based study of 532 cases
- PMID: 2010773
- DOI: 10.1097/00005072-199103000-00005
Medulloblastoma: a population-based study of 532 cases
Abstract
Five hundred thirty-two cases of medulloblastoma (males n = 327 and females n = 205), aged 0 to 86 years diagnosed between 1973 and 1986 were studied to determine the incidence in different geographic regions of the United States and to evaluate the effect of various factors on survival. The median age was 9 years and average follow-up time was 45 months. The overall incidence rate was 1.8 per one million person-years. Variables that were statistically significant (p less than 0.05) in a multivariate model determining survival in rank order were treatment group, sex, geographic region, year group and age. This observational study found that 1) age and sex were statistically significant factors in describing the incidence rates, whereas year group and geographic region were not; 2) no incidence peak in the third decade of life was observed; 3) a significant improvement in survival was observed in the combined 1978 to 1986 year groups relative to the 1973 to 1977 year group; 4) the overall 5-year survival probability was 45%; and 5) there has been an increase over time in the use of more than two modalities of treatment.
Similar articles
-
Epidemiology of adult medulloblastoma.Int J Cancer. 1999 Mar 1;80(5):689-92. doi: 10.1002/(sici)1097-0215(19990301)80:5<689::aid-ijc10>3.0.co;2-g. Int J Cancer. 1999. PMID: 10048968
-
Childhood medulloblastoma in northwest England 1954 to 1997: incidence and survival.Dev Med Child Neurol. 2003 May;45(5):308-14. doi: 10.1017/s0012162203000586. Dev Med Child Neurol. 2003. PMID: 12729144
-
Second cancers after medulloblastoma: population-based results from the United States and Sweden.Cancer Causes Control. 1997 Nov;8(6):865-71. doi: 10.1023/a:1018464328836. Cancer Causes Control. 1997. PMID: 9427429
-
Risk-adapted chemotherapy in childhood medulloblastoma.Expert Rev Anticancer Ther. 2011 May;11(5):771-80. doi: 10.1586/era.10.222. Expert Rev Anticancer Ther. 2011. PMID: 21554052 Review.
-
Medulloblastoma: recent advances and directions in diagnosis and management--Part I.Curr Probl Cancer. 1984 May;8(11):4-54. doi: 10.1016/s0147-0272(84)80011-2. Curr Probl Cancer. 1984. PMID: 6383718 Review. No abstract available.
Cited by
-
The invasiveness of five medulloblastoma cell lines in collagen gels.J Neurooncol. 2010 Jan;96(2):181-9. doi: 10.1007/s11060-009-9962-9. Epub 2009 Jul 15. J Neurooncol. 2010. PMID: 19847623
-
MicroCT-based virtual histology evaluation of preclinical medulloblastoma.Mol Imaging Biol. 2011 Jun;13(3):493-499. doi: 10.1007/s11307-010-0372-3. Mol Imaging Biol. 2011. PMID: 20617390 Free PMC article.
-
The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system.Br J Cancer. 2002 Apr 8;86(7):1117-23. doi: 10.1038/sj.bjc.6600151. Br J Cancer. 2002. PMID: 11953859 Free PMC article.
-
Primary Leptomeningeal Medulloblastoma in Adults: A Diagnostic Challenge-Case Report and Systematic Review.Asian J Neurosurg. 2022 Oct 29;17(4):651-655. doi: 10.1055/s-0042-1757726. eCollection 2022 Dec. Asian J Neurosurg. 2022. PMID: 36570761 Free PMC article.
-
Viruses and human brain tumors: cytomegalovirus enters the fray.J Clin Invest. 2011 Oct;121(10):3831-3. doi: 10.1172/JCI60005. J Clin Invest. 2011. PMID: 21968105 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources